(CNN) -
A pediatric trial of the Oxford-AstraZeneca vaccine has been halted pending a review by the UK drug regulator of rare cases of blood clots in adults, an Oxford University spokesperson told CNN. on Tuesday.
“While there are no safety concerns in the pediatric clinical trial, we await additional information from the [Medicines and Health Products Regulatory Agency] on their review of rare cases of thrombosis / thrombocytopenia that have been reported in adults, before administering more vaccines in rehearsal, ”the spokesperson said.
"Parents and children should continue to attend all scheduled visits and can contact the testing sites if they have any questions," they added.